Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 8/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | TP53 | P04637 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | MITF | O75030 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nifuratel SCHEMBL365913 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL1649685 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL15375600 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL153098 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL16675657 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL15068213 | 1.00 | HIF1A (0.68) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL28338979 | 0.99 | HIF1A (0.67) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL28086242 | 0.93 | LMNA (0.70) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL1237293 | 0.89 | HIF1A (0.56) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Nifuratel SCHEMBL27952170 | 0.88 | HIF1A (0.55) | HIF1AKMT2AUSP2MAPK9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4216 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| EP-4637829-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF OVARIAN CANCER | Cellis Sp. z o.o. ([Ltd.] (PL) | 2025-10-29 | — | — | EP | claimed |
| EP-4587062-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | Cellis AG (CH) | 2025-07-23 | — | — | EP | claimed |
| US-20250222066-A1 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2025-07-10 | — | — | US | claimed |
| EP-4101437-B1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2025-06-11 | — | — | EP | claimed |
| EP-4547023-A2 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | University of Utah Research Foundation (US) | 2025-05-07 | — | — | EP | claimed |
| CN-119907692-A | Isolated targeted delivery system for the treatment of gliomas | 塞尔丽思股份公司 | 2025-04-29 | — | — | CN | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| EP-0852494-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5635540-A | STABLE MIXTURE OF ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER AND WATER AS CARRIER FOR ANTIBIOTICS, FUNGICIDES OR ANESTHETICS, FOR TREATING SKIN DISEASES, BURNS, WOUNDS | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1997-06-03 | — | — | US | claimed |
| WO-1997009973-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-20 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0306389-B1 | USE OF MICROCAPSULES IN THE MANUFACTURE OF AN ELASTOMERIC PROPHYLACTIC DEVICE, SUCH AS A CONDOM OR THE LIKE, AND ITS MANUFACTURING PROCESS | HUTCHINSON (FR) | 1992-07-08 | — | — | EP | claimed |
| EP-0306389-A1 | Use of microcapsules in the manufacture of an elastomeric prophylactic device, such as a condom or the like, and its manufacturing process | HUTCHINSON (FR) | 1989-03-08 | — | — | EP | claimed |